Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to preservation that represents a significant improvement over the traditional standard of care.
Paragonix Advanced Organ Preservation devices combine clinically-proven, stable cooling techniques with digital tracking and monitoring technologies to provide clinicians complete control and oversight throughout the donor organ journey. The clinical impact of Paragonix preservation technology is reinforced by the GUARDIAN clinical registries, the largest database of organ preservation data in the world that analyzes post-transplant outcomes in transplant recipients.
Paragonix to Participate in 23rd Annual Needham Growth Conference in 2021
CAMBRIDGE, MASSACHUSETTS, January 4, 2020 — Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today that Bill Edelman, Chief Executive Officer and Chairman of the Board, will present at in the 23rdAnnual Needham Virtual Growth Conference on January 11-15th, 2021 in a series of virtual 1:1 meetings reviewing the company’s rapid international growth to over 500 heart transplant systems shipped, expanding product portfolio to lung and digital products, and projections for 2021.
For more information contact: https://pgnx.info/38GRy2c